Bl-1020

· BioLineRx, Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Bl-1020, covering 2009-07-21 to 2014-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia [Phase 2, Phase 3]